Ligand validation:9IKI

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IKI_LFA_N_608	41%	91%	0.169	0.937	0.29	0.29	-	-	5	0	70%	0.6
9IKI_LFA_P_312	31%	78%	0.173	0.885	0.61	0.28	-	-	2	0	75%	0.6
9IKI_LFA_A_607	28%	90%	0.208	0.917	0.37	0.24	-	-	7	0	70%	0.6
9IKI_LFA_C_309	23%	92%	0.226	0.869	0.32	0.19	-	-	2	0	90%	0.4
9IKI_LFA_P_309	21%	92%	0.239	0.864	0.3	0.25	-	-	2	0	90%	0.4
9IKI_LFA_B_307	18%	87%	0.279	0.893	0.43	0.26	-	-	4	0	85%	0.6
9IKI_LFA_C_314	17%	85%	0.227	0.851	0.29	0.44	-	-	3	0	75%	0.6
9IKI_LFA_O_302	14%	93%	0.284	0.868	0.24	0.24	-	-	3	0	85%	0.6
9IKI_LFA_C_310	11%	96%	0.315	0.874	0.26	0.1	-	-	0	0	75%	0.4
9IKI_LFA_T_101	10%	72%	0.263	0.824	0.66	0.43	-	-	6	0	70%	0.6
9IKI_LFA_C_315	10%	96%	0.264	0.832	0.21	0.14	-	-	1	0	65%	0.6
9IKI_LFA_P_313	10%	90%	0.272	0.84	0.32	0.29	-	-	0	0	65%	0.6
9IKI_LFA_G_104	10%	83%	0.267	0.822	0.52	0.27	-	-	5	0	70%	0.6
9IKI_LFA_C_311	9%	95%	0.277	0.853	0.24	0.16	-	-	0	0	55%	0.5
9IKI_LFA_T_103	9%	96%	0.306	0.854	0.2	0.16	-	-	0	0	70%	0.5
9IKI_LFA_C_307	8%	95%	0.299	0.852	0.19	0.21	-	-	3	0	55%	0.4
9IKI_LFA_T_104	8%	89%	0.299	0.847	0.34	0.31	-	-	0	0	55%	0.6
9IKI_LFA_C_313	7%	91%	0.284	0.83	0.33	0.23	-	-	1	0	55%	0.5
9IKI_LFA_P_307	6%	93%	0.326	0.836	0.26	0.21	-	-	1	0	55%	0.4
9IKI_LFA_O_303	5%	93%	0.333	0.829	0.3	0.19	-	-	1	0	55%	0.6
9IKI_LFA_P_311	5%	92%	0.301	0.787	0.24	0.28	-	-	1	0	55%	0.5
9IKI_LFA_C_326	4%	94%	0.376	0.811	0.27	0.18	-	-	0	0	75%	0.4
9IKI_LFA_P_308	3%	96%	0.355	0.814	0.21	0.17	-	-	0	0	30%	0.4
9IKI_LFA_C_312	2%	94%	0.39	0.754	0.25	0.19	-	-	0	0	70%	0.5
9IKI_LFA_C_308	2%	93%	0.423	0.824	0.28	0.19	-	-	0	0	30%	0.4
9IKI_LFA_P_310	2%	96%	0.401	0.736	0.22	0.13	-	-	0	0	55%	0.5
9IKG_LFA_P_313	33%	92%	0.187	0.912	0.27	0.24	-	-	0	0	75%	0.6
9KUM_LFA_P_313	32%	90%	0.187	0.908	0.38	0.22	-	-	1	0	75%	0.6
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.4
9KUK_LFA_P_314	30%	86%	0.19	0.896	0.46	0.26	-	-	3	0	75%	0.6
9IKH_LFA_N_609	29%	86%	0.203	0.915	0.33	0.38	-	-	6	0	70%	0.6
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.